The Influenza A Virus: 2009 H1N1 Subtype (Online Course)
(based on 2159 customer ratings)
The "Swine Flu," as it was originally dubbed, created an upsurge in laboratory Flu testing in several areas of the United States and other countries as well. Suggested protocols for detecting and monitoring H1N1 virus were frequently published and updated throughout the spring, summer, and fall of 2009. This course will provide you with the laboratory and clinical policies and procedures that sifted out and are currently recommended by the CDC, WHO, and other national and international healthcare surveillance groups. Some may consider this course a retrospective, but the possibility of the Influenza A H1N1 virus re-emerging should encourage all laboratory and other healthcare personnel to expand their knowledge of the laboratory and clinical aspects of this virus.
Continuing Education Credits
- P.A.C.E.® Contact Hours: 1 hour(s)
- Florida Board of Clinical Laboratory Science - General (Serology/Immunology): 1 hour(s)
- Describe the characteristics and epidemiology of the novel 2009 influenza A H1N1 virus.
- Identify the pathophysiology including the signs and symptoms of the novel 2009 influenza A H1N1 virus.
- Recognize the role of the clinical laboratory in H1N1 virus testing.
- Review important infection control protocols and procedures for healthcare employees.
- List the treatment and vaccination options for the 2009 H1N1 virus.
- Describe the surveillance system in place for the novel 2009 influenza A H1N1 virus.
(based on 2159 customer ratings)
Click on a link in the outline to view a sample page from this course.
- Introduction to the Influenza A 2009 H1N1 Virus
- Epidemiology of the Influenza A 2009 H1N1 virus
- Signs and Symptoms of the Influenza A 2009 H1N1 virus
- Signs and Symptoms of the H1N1 Virus
- How Severe is the Illness?
- Which of the following is NOT a typical symptom associated with the 2009 H1N1 virus?
- Statistics related to the Influenza A 2009 H1N1 Virus
- Impact of the 2009 H1N1 Virus
- WHO Declaration of Pandemic
- According to the Centers for Disease Control and Prevention (CDC), which group of individuals have been most impacted by the 2009 H1N1 virus?
- Laboratory Evaluation of the Influenza A 2009 H1N1 virus
- Guidelines for Diagnostic Testing and Treatment
- Laboratory Tests
- Specimen Collection and Storage
- Which of these laboratory methods is the most sensitive and specific for the 2009 Influenza A H1N1 virus?
- Infection control
- Survival of the Influenza A 2009 H1N1 Virus
- Contact Precautions for Laboratorians
- How long can influenza A viruses survive on a hard surface?
- Prevention and Treatment of the Influenza A 2009 H1N1 Virus
- Treatment Options for H1N1 Infection
- H1N1 Vaccine
- Prevention of H1N1 Infection
- Which of the following would be effective methods to reduce the risk of becoming infected with the H1N1 virus?
- Surveillance of the Influenza A 2009 H1N1 Virus
- Resources for CDC Surveillance Information
- CDC Surveillance of the Influena A 2009 H1N1 Virus
- Other CDC Actions for the Influenza A 2009 H1N1 Virus
- FDA Surveillance and H1N1 Preparedness
- WHO Surveillance
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical technologists, and technicians, This course is also appropriate for other healthcare personnel, medical laboratory science students, and pathology residents.
Author information: Leah Beck, MPH, CLS(NCA), MT(ASCP) is the Director of the Clinical Laboratory Science Program at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania
. She holds a Masters in Public Health from Thomas Jefferson University
Reviewer information: Alan T. Evangelista, PhD, is the Director of Microbiology, Virology, and Molecular Diagnostics in the Department of Pathology and Laboratory Medicine at St. Christopher’s Hospital for Children in Philadelphia, PA. He
received his doctorate in Microbiology from the University
and Dentistry of New Jersey in Newark
, and completed a postdoctoral fellowship in Medical and Public Health Microbiology at Temple University School of Medicine in Philadelphia.
Dr. Evangelista is a diplomate of the American Board of Medical Microbiology. He has published numerous abstracts, papers, and book chapters on topics related to infectious diseases and antimicrobial resistance.
Course description: The novel 2009 H1N1 virus was something new that, although resembling some influenza A viruses in the past, had some characteristics that distinguished it as a new virus that was quickly reaching pandemic status during the spring of 2009. This course discusses the characteristics and epidemiology of the novel 2009 H1N1 virus, the clinical aspects of the illness, and the laboratory's role in providing information for diagnosis and treatment. The various organizations that are involved in gathering and disseminating i
The Influenza A Virus: 2009 H1N1 Subtype Keywords
These are the most common topics and keywords covered in The Influenza A Virus: 2009 H1N1 Subtype: